The first clinical trial of a ‘universal’ Sarbeco coronavirus vaccine at 2 NIHR facilities has shown that the vaccine is safe and has no significant side effects.
The study took place at the Southampton Clinical Research Facility (
@SouthamptonCRF) and the Cambridge Clinical Research Facility (
@CambridgeCRF).
It was sponsored by University Hospital Southampton NHS Foundation Trust (
@UHSFT) and recruitment was supported by the Research Delivery Network (
@NIHRrdn).